Advertisement

Cancer Chemotherapy and Pharmacology

, Volume 5, Issue 4, pp 211–215 | Cite as

The use of four-drug combination chemotherapy (D.A.V.E.) in the treatment of advanced Wilms' tumour

  • D. B. Dunger
  • J. S. Malpas
  • J. R. Graham-Pole
  • M. R. Sandland
  • A. G. Stansfeld
  • J. E. Freeman
Original Articles Wilms' Tumour Chemotherapy

Summary

A study was begun in 1971 at St. Bartholomew's Hospital with a combination of 4 drugs, dactinomycin (actinomycin D), adriamycin, vincristine and Endoxan (cyclophosphamide) (D.A.V.E.), together with surgery and radiation, in the treatment of stage III and stage IV Wilms' tumour. Seventy-one percent of the children treated achieved complete response. The median survival from diagnosis was 19 months, and in those children achieving complete response the median disease-free survival has not yet been reached. Toxicity was not a serious problem.

The study group is compared with a group of children treated at this hospital before 1971. There is an improved survival in the children treated with D.A.V.E. Children who have relapsed with stage I or stage II disease may also respond.

This four-drug combination was well tolerated and effective, and confirms recent experience suggesting that intensive multiple-drug regimens may be curative even in advanced disease.

Keywords

Cancer Research Cyclophosphamide Median Survival Advanced Disease Vincristine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Beckwith JB, Palmer NF (1978) Histopathology and prognosis of Wilms' tumour. Cancer 41:1937Google Scholar
  2. 2.
    Bellani FF (1975) Adriamycin in Wilms' tumour previously treated with chemotherapy. Eur J Cancer 11:593Google Scholar
  3. 3.
    D'Angio GJ, Farber S (1959) Potentiation of x-ray effects by actinomycin D. Radiology 73:175Google Scholar
  4. 4.
    D'Angio GJ, Beckwith JB (1979) Results of the Second National Wilms' tumour study (NWTS-2). Proc Am Soc Clin Oncol 20:74Google Scholar
  5. 5.
    D'Angio GJ, Beckwith JB (1980) Wilms' tumour: An Update. Cancer 45:1791Google Scholar
  6. 6.
    Farber S (1966) Chemotherapy in the treatment of leukaemia and Wilms' tumour. JAMA 198:826–836Google Scholar
  7. 7.
    Farber S (1960) Clinical studies of actinomycin D with special reference to Wilms' tumour in children. Ann NY Acad Sci 89:421Google Scholar
  8. 8.
    Gross RE, Neuhauser EBD (1950) Treatment of mixed tumours of the kidney in childhood. Pediatrics 6:843Google Scholar
  9. 9.
    Jenkin RDT, Jeffs RD (1976) Wilms' tumour: adjuvant treatment with actinomycin D and Vincristine. CMA Journal 115:136Google Scholar
  10. 10.
    Margolis LW, Byron Smith (1973) Wilms' tumour — An interdisciplinary treatment program with and without actinomycin D Cancer 32:618Google Scholar
  11. 11.
    Ortega JA, Higgins GR (1980) Vincristine, dactinomycin and cyclophosphamide (VAC) chemotherapy for recurrent metastatic Wilms' tumour in previously treated children. J Paediatr 96:502Google Scholar
  12. 12.
    Pinedo HM, Kenis Y (1977) Chemotherapy of advanced soft-tissue sarcoma in adults. Cancer Treat Rev 4:67Google Scholar
  13. 13.
    Sutow WW (1967) Cyclophosphamide in Wilms' tumour and rhabdomyosarcoma. Cancer Chemother Rep 51:407Google Scholar
  14. 14.
    Sutow WW, Thurman WG, Windmiller J (1963) Vincristine (Leurocristine) sulfate in the treatment of children with metastatic Wilms' tumour. Pediatrics 32:880Google Scholar
  15. 15.
    Vietti TJ, Sullivan MP (1970) Vincristine sulfate and radiation therapy in metastatic Wilm's tumour. Cancer 25:12Google Scholar

Copyright information

© Springer-Verlag 1981

Authors and Affiliations

  • D. B. Dunger
    • 1
  • J. S. Malpas
  • J. R. Graham-Pole
    • 2
  • M. R. Sandland
  • A. G. Stansfeld
  • J. E. Freeman
    • 3
  1. 1.The Hospital for Sick ChildrenLondonGreat Britain
  2. 2.Department of Hematology/OncologyRainbow Babies and Children's HospitalCleveland
  3. 3.Cancer Therapy and Research CentreCancer Therapy and Research Foundation of South TexasSan AntonioUSA

Personalised recommendations